Akerna Corp. (KERN) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $0.31, Akerna Corp. (KERN) es una empresa del sector Healthcare valorada en 163K. Calificado con 43/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 8 feb 2026Akerna Corp. (KERN) Resumen de Asistencia Médica y Tuberías
Akerna Corp. is a leading provider of compliance and inventory management software for the cannabis industry, offering a comprehensive seed-to-sale platform and data analytics solutions, positioning it to capitalize on the expanding legal cannabis market in the US and Canada.
Tesis de Inversión
Akerna presents a notable research candidate due to its strategic positioning within the rapidly expanding legal cannabis market. The company's comprehensive seed-to-sale platform, coupled with its government regulatory software, provides a unique value proposition in a highly regulated industry. With a gross margin of 42.4%, Akerna demonstrates its ability to generate profitability from its software solutions. The increasing legalization of cannabis across North America serves as a significant growth catalyst, driving demand for Akerna's compliance and inventory management tools. While the company's negative P/E ratio of -15.93 and negative profit margin of -22.8% indicate current challenges, the potential for revenue growth in a burgeoning market, combined with operational efficiencies, could lead to improved financial performance and increased shareholder value.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Akerna operates in the rapidly growing cannabis, hemp, and CBD industry, poised for expansion as legalization efforts continue.
- The company's MJ Platform offers a comprehensive seed-to-sale solution, addressing critical compliance and inventory management needs.
- Leaf Data Systems provides government regulatory software, demonstrating Akerna's commitment to supporting regulatory compliance.
- Akerna's gross margin of 42.4% indicates a strong ability to generate profit from its software solutions.
- The company's beta of 2.79 suggests higher volatility compared to the overall market, reflecting the growth potential and risk associated with the cannabis industry.
Competidores y Pares
Fortalezas
- Comprehensive seed-to-sale platform
- Regulatory expertise and government software
- Established customer base in the cannabis industry
- Data analytics capabilities
Debilidades
- Negative P/E ratio and profit margin
- High beta indicating volatility
- Dependence on the cannabis industry
- Limited geographic diversification
Catalizadores
- Upcoming: Further legalization of cannabis in additional states and countries, driving demand for compliance software.
- Ongoing: Expansion of Akerna's product offerings to include new features and functionalities.
- Ongoing: Strategic partnerships and acquisitions to expand market reach and product portfolio.
Riesgos
- Potential: Increasing competition in the cannabis software market, potentially leading to price pressure.
- Potential: Changes in cannabis regulations, requiring Akerna to adapt its software and services.
- Potential: Economic downturn impacting cannabis businesses, reducing demand for Akerna's solutions.
- Ongoing: Cybersecurity risks, potentially compromising customer data and disrupting operations.
Oportunidades de crecimiento
- Expansion into New Geographies: As more states and countries legalize cannabis, Akerna has the opportunity to expand its operations into new markets. This expansion can be achieved through direct sales, partnerships, or acquisitions. The global legal cannabis market is projected to reach billions of dollars in the coming years, providing a substantial growth runway for Akerna.
- Product Innovation and Development: Akerna can further enhance its product offerings by developing new features and functionalities for its MJ Platform and Leaf Data Systems. This includes incorporating advanced analytics, artificial intelligence, and machine learning to provide more insights and automation for its customers. Continuous innovation will help Akerna maintain its competitive edge and attract new customers.
- Strategic Partnerships and Acquisitions: Akerna can pursue strategic partnerships and acquisitions to expand its product portfolio, geographic reach, and customer base. This includes partnering with other technology providers, cannabis industry consultants, and regulatory experts. Acquisitions can provide access to new technologies, markets, and talent.
- Increased Focus on Data Analytics: Akerna can leverage its vast data resources to provide valuable insights and analytics to its customers. This includes offering customized reports, benchmarking data, and predictive analytics to help cannabis businesses optimize their operations, improve compliance, and increase profitability. Data analytics can become a significant revenue stream for Akerna.
- Penetration of the Hemp and CBD Market: While Akerna has a presence in the hemp and CBD market, there is significant opportunity to further penetrate this segment. The hemp and CBD market is experiencing rapid growth, driven by increasing consumer awareness and demand for these products. Akerna can tailor its solutions to meet the specific needs of hemp and CBD businesses, capturing a larger share of this market.
Oportunidades
- Expansion into new geographic markets
- Product innovation and development
- Strategic partnerships and acquisitions
- Increased focus on data analytics
Amenazas
- Increasing competition in the cannabis software market
- Changing cannabis regulations
- Economic downturn impacting cannabis businesses
- Cybersecurity risks
Ventajas competitivas
- Comprehensive Seed-to-Sale Platform: Akerna's MJ Platform offers a complete solution for tracking cannabis products from seed to sale, providing a competitive advantage over point solutions.
- Regulatory Expertise: The company's deep understanding of cannabis regulations and its Leaf Data Systems software provide a barrier to entry for competitors.
- Established Customer Base: Akerna has an established customer base in the cannabis industry, providing a recurring revenue stream and a competitive advantage.
- Data Analytics Capabilities: Akerna's data analytics capabilities provide valuable insights to its customers, differentiating it from competitors.
Acerca de KERN
Founded in 2010 and headquartered in Denver, Colorado, Akerna Corp. emerged as a key player in the burgeoning cannabis industry by providing essential software solutions. Recognizing the complex regulatory landscape and the need for efficient inventory management, Akerna developed the MJ Platform, a comprehensive seed-to-sale platform designed for cannabis, hemp, and CBD businesses. This platform offers tracking, reporting, and compliance tools crucial for cultivators, processors, sellers, and clinics. Akerna's commitment extends beyond commercial enterprises, as evidenced by Leaf Data Systems, a government regulatory software solution. This offering underscores Akerna's dedication to supporting regulatory compliance at all levels. The company further enhances its value proposition through consulting services tailored to the cannabis industry, along with business intelligence, data analytics, and other software-related services. Akerna also provides Last Call Analytics, a tool designed for alcohol brands to analyze their retail sales data. Akerna's comprehensive suite of solutions positions it as a vital partner for businesses navigating the complexities of the cannabis and related industries.
Qué hacen
- Provides seed-to-sale tracking software for the cannabis industry.
- Offers regulatory compliance solutions for cannabis businesses.
- Develops inventory management systems for cannabis cultivators, processors, and retailers.
- Provides data analytics and business intelligence tools.
- Offers consulting services to cannabis businesses.
- Develops government regulatory software for cannabis tracking.
- Provides solutions for the hemp and CBD industry.
- Offers retail sales analytics for alcohol brands.
Modelo de Negocio
- Software as a Service (SaaS): Akerna generates revenue through recurring subscription fees for its MJ Platform and Leaf Data Systems.
- Consulting Services: The company earns revenue from providing consulting services to cannabis businesses.
- Data Analytics: Akerna generates revenue from providing data analytics and business intelligence services.
- Software Related Services: The company earns revenue from other software related services.
Contexto de la Industria
Akerna operates within the medical and healthcare information services sector, specifically catering to the cannabis industry. The legal cannabis market is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. This growth necessitates robust compliance and inventory management solutions, creating a significant demand for Akerna's offerings. The competitive landscape includes companies like ATLN (Atlantic Coastal Healthcare Acquisition Corp), BLPH (BioLineRx Ltd), CMAX (CareMax Inc), HSTO (Histogen Inc), and HUGE (FSD Pharma Inc), some of which offer overlapping or complementary services. Akerna differentiates itself through its comprehensive seed-to-sale platform and government regulatory software.
Clientes Clave
- Cannabis cultivators
- Cannabis processors
- Cannabis retailers
- Cannabis clinics
- Government regulatory bodies
Finanzas
Gráfico e información
Precio de la acción de Akerna Corp. (KERN): $0.31 (+0.08, +36.94%)
Últimas noticias
-
12 Information Technology Stocks Moving In Thursday's After-Market Session
benzinga · 14 dic 2023
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · 17 nov 2022
-
Earnings Scheduled For May 9, 2022
benzinga · 9 may 2022
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · 28 abr 2022
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para KERN.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para KERN.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de KERN en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Últimas Noticias
Preguntas Comunes Sobre KERN
¿Cuáles son los factores clave para evaluar KERN?
Akerna Corp. (KERN) actualmente tiene una puntuación IA de 43/100, indicando puntuación baja. Fortaleza clave: Comprehensive seed-to-sale platform. Riesgo principal a monitorear: Potential: Increasing competition in the cannabis software market, potentially leading to price pressure.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de KERN?
KERN actualmente puntúa 43/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de KERN?
Los precios de KERN se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre KERN?
La cobertura de analistas para KERN incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en KERN?
Las categorías de riesgo para KERN incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Increasing competition in the cannabis software market, potentially leading to price pressure.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de KERN?
La relación P/E para KERN compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está KERN sobrevalorada o infravalorada?
Determinar si Akerna Corp. (KERN) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de KERN?
Akerna Corp. (KERN) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Stock data pending update. Financial data may be outdated.